ID: ALA4871208

Max Phase: Preclinical

Molecular Formula: C28H26BN5O5

Molecular Weight: 523.36

Molecule Type: Unknown

Representations

Canonical SMILES:  Cc1cc2c(NC(=O)c3ccco3)cccc2n1-c1nc2c(c(NCc3cccc(B(O)O)c3)n1)COCC2

Standard InChI:  InChI=1S/C28H26BN5O5/c1-17-13-20-22(31-27(35)25-9-4-11-39-25)7-3-8-24(20)34(17)28-32-23-10-12-38-16-21(23)26(33-28)30-15-18-5-2-6-19(14-18)29(36)37/h2-9,11,13-14,36-37H,10,12,15-16H2,1H3,(H,31,35)(H,30,32,33)

Standard InChI Key:  CSAOOHPSIAXBEN-UHFFFAOYSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Unknown

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 523.36

Molecular Weight (Monoisotopic): 523.2027

AlogP:

#Rotatable Bonds:

Polar Surface Area:

Molecular Species:

HBA:

HBD:

#RO5 Violations:

HBA (Lipinski):

HBD (Lipinski):

#RO5 Violations (Lipinski):

CX Acidic pKa:

CX Basic pKa:

CX LogP:

CX LogD:

Aromatic Rings:

Heavy Atoms:

QED Weighted:

Np Likeness Score:

References

1. Zhang Y, Xie X, Wang X, Wen T, Zhao C, Liu H, Zhao B, Zhu Y..  (2021)  Discovery of novel pyrimidine molecules containing boronic acid as VCP/p97 Inhibitors.,  38  [PMID:33831696] [10.1016/j.bmc.2021.116114]

Source

Source(1):

• Scientific Literature